ClinicalTrials.gg
RecruitingNCT07608653Updated Jun 1, 2026

Outcomes of Laparoscopic Keyhole Surgery (TAPP) for Recurrent Inguinal Hernia

An interventional study of Laparoscopic Transabdominal Preperitoneal (TAPP) Repair in Recurrant Inguinal Hernia, sponsored by Sohag University. Recruiting at 1 site in Egypt. Per ClinicalTrials.gov, last updated 2026-06-01.

Sponsored by Sohag University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jul 2026, 4 months ago, but the record still lists the study as recruiting.
  • Started Apr 2026; still recruiting 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Not applicable
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 45 studies in Hernia, Inguinal with a site in Egypt — 16 open to participants now, 17 under way, 1 of them phase 3. Hernia, Inguinal · Egypt.

Planned enrollment
43rd of 43
10 · median 60
Started
2026
with 5 others
No phase
38 of 45
14 open now
Primary completion
2026-07
later than 11 of 16 live
Registered
38th of 45
by date
Lead sponsor
6 of 45
Sohag University

Among the 45 studies in Hernia, Inguinal with a site in Egypt, this one is the 43rd largest by planned enrollment of the 43 interventional ones that give a count, is one of 6 that started in 2026, is one of 38 with no phase, reaches primary completion later than 11 of the 16 other live ones, and was the 38th registered.

Hernia, Inguinal

545 studies on the registry are indexed under Hernia, Inguinal; 91 are open to participants now.

Browse Hernia, Inguinal studies →

Open to participants now

16 of the 45 studies in Hernia, Inguinal with a site in Egypt are open now. Recruiting first, the newest first:

10 more — sign in →

All 16 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 54 Hernia, Inguinal studies recruiting now, 30 (56%) set no upper age limit and 16 (30%) stop at 75 or younger; 16 take children under 18; 9 take healthy volunteers.

This study: all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 45 studies in Hernia, Inguinal with a site in Egypt, or all of them as a file.
02

Study summary

The goal of this clinical trial is to learn if a laparoscopic surgery called Transabdominal Preperitoneal (TAPP) repair is safe and works well for adults with a recurrent inguinal hernia (a groin hernia that has returned after a previous operation).

The main questions it aims to answer are:

Does the TAPP technique lower the number of complications after surgery? How well do participants recover during the early postoperative period and long-term follow-up? Fixing a hernia that has returned is hard because of old scar tissue. In this study, researchers will use the TAPP technique to work through a different layer of tissue to provide a stronger repair.

Participants will:

Undergo the TAPP laparoscopic surgery for their recurrent hernia. Visit the clinic for close health monitoring shortly after surgery. Complete regular follow-up checkups to track their long-term recovery.

03

Conditions studied

  • Recurrant Inguinal Hernia

Browse trials for

Keywords

  • Tapp repair
  • Recurrant inguinal hernia
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients. Patients diagnosed with recurrent inguinal hernia. Patients fit for general anesthesia. Patients who provide .

Exclusion criteria

Exclusion Criteria:

  • Non recurrent inguinal hernia Patients with complicated inguinal hernia. Patients unfit for general anesthesia. Patients refusing participation in the study.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
10 participants (estimated)

Study arms

  • Experimental
    Laparoscopic TAPP Repair

    Patients with recurrent inguinal hernia who will undergo laparoscopic transabdominal preperitoneal (TAPP) repair using a synthetic mesh.

    Procedure: Laparoscopic Transabdominal Preperitoneal (TAPP) Repair

Interventions

  • ProcedureLaparoscopic Transabdominal Preperitoneal (TAPP) Repair

    The surgical procedure will be performed under general anesthesia. Standard laparoscopic instruments will be used to access the peritoneal cavity. The peritoneum over the recurrent inguinal hernia site will be incised to enter the preperitoneal space. After reduction of the hernia sac and clearing of post-operative adhesions, a synthetic mesh will be placed to cover the hernia defects. The mesh will be secured if necessary, and the peritoneal flap will be closed using sutures or tacks.

06

What researchers measure

Primary outcomes

  1. Feasibility and Technical Success of Laparoscopic TAPP

    Evaluation of the feasibility of the TAPP approach in recurrent inguinal hernias, measured by the rate of successful laparoscopic completion without the need for intraoperative conversion to open surgery due to severe scar tissue or adhesions.

    Time frame: During the intraoperative procedure (Day of surgery)

Secondary outcomes

  1. Post-operative Pain

    Assessment of pain severity using the Visual Analog Scale (VAS), which ranges from 0 (no pain) to 10 (worst possible pain).

    Time frame: At 24 hours, 1 week, and 1 month post-operatively

  2. Hernia Recurrence

    The percentage of patients who experience another clinical return of the inguinal hernia after the TAPP repair. Recurrence will be detected through physical examination during follow-up, and confirmed by groin ultrasound or CT scan if a hernia is clinically suspected.

    Time frame: 4 months

  3. Operative Time

    The total duration of the surgical procedure calculated in minutes from the skin incision to the final closure

    Time frame: During the surgical procedure (Day of surgery)

  4. Length of Hospital Stay

    The total number of hours or days from the end of the surgery until the patient is officially discharged from the hospital.

    Time frame: From the day of surgery up to hospital discharge (typically 1-2 days)

  5. Incidence of Post-operative Complications

    Detection of any early complications like seroma, hematoma, or wound infection.

    Time frame: Up to 4 months post-operatively

  6. Incidence of Intraoperative Complications

    The percentage of patients experiencing any surgical complications during the operation, such as urinary bladder injury, bowel injury, or major vascular bleeding

    Time frame: During the surgical procedure (Day of surgery)

  7. Time to Return to Normal Daily Activities

    The total number of days taken by the patient to independently resume their baseline activities of daily living and return to light work/routine post-surgery.

    Time frame: Up to 4 months post-operatively

07

Study locations

1 of 1 sites recruiting
  • Faculty of medicine
    Sohag, Egypt
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2026 (actual). Primary completion is estimated for Jul 2026, 3 months after the start.

Of 179 non-industry interventional studies with no phase under Hernia, Inguinal, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 35. This study's planned 3 months is below that.

Counting every sponsor, half of 188 studies reached it within 19 months; a quarter within 9 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
May 20, 2026
First posted
May 27, 2026
StartActual
Apr 1, 2026
Primary completionEst.
Jul 1, 2026
CompletionEst.
Jul 1, 2026
Last update
Jun 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07608653
Lead sponsor
Sohag University
Responsible party
Marwa Nabil Hussien (Resident of General Surgery, Sohag University) — Principal investigator
First posted
May 27, 2026
Start date
Apr 1, 2026
Primary completion
Jul 1, 2026 (estimated)
Completion
Jul 1, 2026 (estimated)
Last update
Jun 1, 2026

Study contacts

marwa Saber, Resident
Contact
marwaelkholy93@gmail.com
01017659722

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion